Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PREEMIE: Study for Treatment of PDA in Premature Infants

NCT: NCT06587282 · ACTIVE_NOT_RECRUITING

NCT IDNCT06587282
StatusACTIVE_NOT_RECRUITING
Start Date2025-03-06
Completion2029-03

Brief Summary

This multicenter, single arm, prospective, non-randomized study is designed to evaluate the safety and effectiveness of The Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in pre-mature infants over a period of 6 months.

Frequently Asked Questions

What is PREEMIE: Study for Treatment of PDA in Premature Infants?

PREEMIE: Study for Treatment of PDA in Premature Infants is a clinical trial registered under NCT06587282. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06587282?

The current status of NCT06587282 (PREEMIE: Study for Treatment of PDA in Premature Infants) is: ACTIVE_NOT_RECRUITING.

When did PREEMIE: Study for Treatment of PDA in Premature Infants start?

PREEMIE: Study for Treatment of PDA in Premature Infants started on 2025-03-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑